AddLife Past Earnings Performance

Past criteria checks 2/6

AddLife has been growing earnings at an average annual rate of 8.9%, while the Life Sciences industry saw earnings growing at 30.7% annually. Revenues have been growing at an average rate of 24.2% per year. AddLife's return on equity is 1.6%, and it has net margins of 0.8%.

Key information

8.9%

Earnings growth rate

6.9%

EPS growth rate

Life Sciences Industry Growth31.8%
Revenue growth rate24.2%
Return on equity1.6%
Net Margin0.8%
Next Earnings Update15 Jul 2024

Recent past performance updates

Recent updates

Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?

Apr 22
Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?

Is It Time To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Apr 06
Is It Time To Consider Buying AddLife AB (publ) (STO:ALIF B)?

AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Feb 07
AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

AddLife AB (publ)'s (STO:ALIF B) 28% Share Price Surge Not Quite Adding Up

Dec 19
AddLife AB (publ)'s (STO:ALIF B) 28% Share Price Surge Not Quite Adding Up

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Dec 09
AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Is It Too Late To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Nov 21
Is It Too Late To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?

Oct 14
Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Sep 08
AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?

Aug 18
Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Jul 05
Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?

May 18
Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?

Is AddLife (STO:ALIF B) Using Too Much Debt?

Apr 28
Is AddLife (STO:ALIF B) Using Too Much Debt?

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Apr 05
AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Feb 21
AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20

Feb 07
AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Jan 20
Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet

Dec 30
AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Oct 27
Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Oct 11
Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Is AddLife (STO:ALIF B) A Risky Investment?

Sep 23
Is AddLife (STO:ALIF B) A Risky Investment?

When Should You Buy AddLife AB (publ) (STO:ALIF B)?

Jul 11
When Should You Buy AddLife AB (publ) (STO:ALIF B)?

Is AddLife (STO:ALIF B) Using Too Much Debt?

Jun 25
Is AddLife (STO:ALIF B) Using Too Much Debt?

A Look At The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Jun 05
A Look At The Fair Value Of AddLife AB (publ) (STO:ALIF B)

AddLife's (STO:ALIF B) Dividend Will Be Increased To kr2.00

May 02
AddLife's (STO:ALIF B) Dividend Will Be Increased To kr2.00

AddLife's (STO:ALIF B) Dividend Will Be Increased To kr2.00

Apr 17
AddLife's (STO:ALIF B) Dividend Will Be Increased To kr2.00

AddLife (STO:ALIF B) Has Announced That It Will Be Increasing Its Dividend To kr2.00

Mar 29
AddLife (STO:ALIF B) Has Announced That It Will Be Increasing Its Dividend To kr2.00

AddLife (STO:ALIF B) Has A Rock Solid Balance Sheet

Mar 27
AddLife (STO:ALIF B) Has A Rock Solid Balance Sheet

AddLife (STO:ALIF B) Is Paying Out A Larger Dividend Than Last Year

Mar 07
AddLife (STO:ALIF B) Is Paying Out A Larger Dividend Than Last Year

Calculating The Intrinsic Value Of AddLife AB (publ) (STO:ALIF B)

Mar 06
Calculating The Intrinsic Value Of AddLife AB (publ) (STO:ALIF B)

Revenue & Expenses Breakdown
Beta

How AddLife makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:ALIF B Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 249,798783,03096
31 Dec 239,6851903,00797
30 Sep 239,4672932,93794
30 Jun 239,2483882,84791
31 Mar 238,9624292,75488
31 Dec 229,0844802,65681
30 Sep 228,8895972,44166
30 Jun 228,6396152,25355
31 Mar 228,8367182,13143
31 Dec 217,9937191,81934
30 Sep 217,5937591,65233
30 Jun 216,9847481,45131
31 Mar 215,9566901,18026
31 Dec 205,2735181,13624
30 Sep 204,5303491,07423
30 Jun 204,0912481,06923
31 Mar 203,6871601,05024
31 Dec 193,4791411,00724
30 Sep 193,17613692123
30 Jun 192,95213484423
31 Mar 192,73013877822
31 Dec 182,48212970820
30 Sep 182,46512571019
30 Jun 182,40412370019
31 Mar 182,35411767918
31 Dec 172,33312066718
30 Sep 172,27712963515
30 Jun 172,16912559310
31 Mar 172,0621225586
31 Dec 161,9391125282
30 Sep 161,799905110
30 Jun 161,760825010
31 Mar 161,562784460
31 Dec 151,394783830
31 Mar 151,057802890
31 Mar 14984782730

Quality Earnings: ALIF B has high quality earnings.

Growing Profit Margin: ALIF B's current net profit margins (0.8%) are lower than last year (4.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALIF B's earnings have grown by 8.9% per year over the past 5 years.

Accelerating Growth: ALIF B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ALIF B had negative earnings growth (-81.8%) over the past year, making it difficult to compare to the Life Sciences industry average (46.4%).


Return on Equity

High ROE: ALIF B's Return on Equity (1.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.